Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study
暂无分享，去创建一个
D. Chauveau | Kihyun Kim | E. Kastritis | G. Merlini | S. Schönland | M. Rosenzweig | J. Vermeulen | K. Gries | J. Fastenau | N. Tran | B. Weiss | M. Minnema | G. Palladini | V. Hungria | M. Cibeira | V. Sanchorawala | A. Jaccard | R. Comenzo | Kenshi Suzuki | S. Gibbs | M. Gatt | E. Libby | Jin Lu | X. Qin | P. Mollee | J. Valent | C. Venner | S. Wong | B. Tromp | Hans C. Lee | S. Vasey | N. Bumma | A. Wechalekar | M. Beksaç